Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhongshan Kekekang Pharmaceutical is a modern pharmaceutical company based in Zhongshan, China, specializing in the research, development, manufacturing, and sales of over-the-counter (OTC) and prescription drugs. Operating as a wholly-owned subsidiary and the industrial manufacturing center of the major retail pharmacy chain Dashenlin, the company produces a wide range of products across four main dosage forms: tablets, capsules, granules, and mixtures. Its portfolio includes traditional Chinese medicines (TCM) and chemical drugs covering therapeutic areas such as respiratory (cold and cough), cardiovascular (antihypertensives), gastrointestinal, and endocrine (hyperthyroidism) health. Notable products include Shimaiqing Mixture (石麦清合剂) for hyperthyroidism, Fuke'an Tablets (腹可安片), and Ganmaoling Granules (感冒灵颗粒).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 中山可可康制药.